{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:57:42Z","timestamp":1787687862940,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jacc.2021.04.087","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T17:22:00Z","timestamp":1624900920000},"page":"27-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary\u00a0Revascularization"],"prefix":"10.1016","volume":"78","author":[{"given":"Hideyuki","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie Pieter","family":"Kappetein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.F.M.","family":"Thuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Milojevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Noack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich-Wilhelm","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piroze M.","family":"Davierwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2021.04.087_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.087_bib2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.04.087_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4244\/EIJ-D-19-00543A","article-title":"The SYNTAX score on its way out or . . . towards artificial intelligence: part I","volume":"16","author":"Serruys","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2021.04.087_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4244\/EIJ-D-19-00543B","article-title":"The SYNTAX score on its way out or . . . towards artificial intelligence: part II","volume":"16","author":"Serruys","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2021.04.087_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/hrt.2009.188607","article-title":"The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction","volume":"96","author":"Bramlage","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2021.04.087_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2013.01.033","article-title":"Reduction of Atherothrombosis for Continued Health Registry Investigators. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2021.04.087_bib7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.087_bib8","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.116.024531","article-title":"Dual Antiplatelet Therapy Study Investigators. Impact of optimal medical therapy in the Dual Antiplatelet Therapy Study","volume":"134","author":"Resor","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.087_bib9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.115.021183","article-title":"Coronary artery bypass graft versus percutaneous coronary intervention: meds matter: impact of adherence to medical therapy on comparative outcomes","volume":"134","author":"Kurlansky","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.087_bib10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","article-title":"Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial","volume":"394","author":"Thuijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.04.087_bib11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ahj.2005.07.017","article-title":"The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase","volume":"151","author":"Ong","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2021.04.087_bib12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.04.087_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.04.087_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcin.2012.03.016","article-title":"A\u00a0global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years","volume":"5","author":"Serruys","year":"2012","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2021.04.087_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(20)32114-0","volume":"396","author":"Takahashi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2021.04.087_bib16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"Fihn","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.athoracsur.2006.10.046","article-title":"Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery","volume":"83","author":"Goyal","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2021.04.087_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2013.277064","article-title":"Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial","volume":"310","author":"Thom","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.04.087_bib19","first-page":"219","article-title":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2021.04.087_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.113.001803","article-title":"Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score","volume":"128","author":"Farooq","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.087_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacc.2012.10.017","article-title":"The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial","volume":"61","author":"Farooq","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib22","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.jacc.2012.03.010","article-title":"Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score","volume":"59","author":"Genereux","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib23","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.jacc.2015.10.023","article-title":"Statistical controversies in reporting of clinical trials: part 2 of a 4-part series on statistics for clinical trials","volume":"66","author":"Pocock","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib24","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","article-title":"Effect of PCI on long-term survival in patients with stable ischemic heart disease","volume":"373","author":"Sedlis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2021.04.087_bib25","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJR.0b013e3283313592","article-title":"Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation","volume":"17","author":"Piepoli","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacc.2021.04.087_bib27","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamacardio.2017.2249","article-title":"Optimal medical therapy for known coronary artery disease: a review","volume":"2","author":"Gibbons","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib28","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib29","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","author":"Hillis","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.04.087_bib30","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.04.087_bib31","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/eurheartj\/ehz714","article-title":"Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry","volume":"41","author":"Bjorklund","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.04.087_bib32","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehs367","article-title":"Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) trial","volume":"33","author":"Farooq","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2021.04.087_bib33","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.799445","article-title":"Impact of statin use on outcomes after coronary artery bypass graft surgery","volume":"118","author":"Kulik","year":"2008","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2021.04.087_bib34","first-page":"II45","article-title":"Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery","volume":"110","author":"Pan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2021.04.087_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1749-8090-5-8","article-title":"Preoperative statin is associated with decreased operative mortality in high risk coronary artery bypass patients","volume":"5","author":"Magovern","year":"2010","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2021.04.087_bib36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MCA.0b013e3283142607","article-title":"Statin therapy is associated with reduced total and cardiovascular mortality after coronary artery bypass grafting surgery","volume":"19","author":"Papathanasiou","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2021.04.087_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2021.04.087_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/icvts\/ivaa042","article-title":"A\u00a0statistical primer on subgroup analyses","volume":"30","author":"Milojevic","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721050154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721050154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:43:42Z","timestamp":1760017422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721050154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0735109721050154"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.04.087","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary\u00a0Revascularization","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.04.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}